NDC 0002-3182

Trulicity

Dulaglutide

Trulicity is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Dulaglutide.

Product ID0002-3182_02015dc8-99de-47b3-b543-5b2a6db567b7
NDC0002-3182
Product TypeHuman Prescription Drug
Proprietary NameTrulicity
Generic NameDulaglutide
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-09-03
Marketing CategoryBLA / BLA
Application NumberBLA125469
Labeler NameEli Lilly and Company
Substance NameDULAGLUTIDE
Active Ingredient Strength5 mg/.5mL
Pharm ClassesGLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0002-3182-61

2 SYRINGE in 1 CARTON (0002-3182-61) > .5 mL in 1 SYRINGE
Marketing Start Date2020-09-30
NDC Exclude FlagN
Sample Package?Y

Drug Details

NDC Crossover Matching brand name "Trulicity" or generic name "Dulaglutide"

NDCBrand NameGeneric Name
0002-1433TrulicityDulaglutide
0002-1434TrulicityDulaglutide
0002-2236TrulicityDulaglutide
0002-3182TrulicityDulaglutide
50090-3483TrulicityDulaglutide
50090-3484TrulicityTrulicity

Trademark Results [Trulicity]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TRULICITY
TRULICITY
86315558 not registered Dead/Abandoned
Eli Lilly and Company
2014-06-20
TRULICITY
TRULICITY
86314558 not registered Dead/Abandoned
Eli Lilly and Company
2014-06-19
TRULICITY
TRULICITY
86271432 5069090 Live/Registered
Eli Lilly and Company
2014-05-05
TRULICITY
TRULICITY
85183667 4786025 Live/Registered
Eli Lilly and Company
2010-11-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.